LL-K8-22

N/A

Report date: 2023/03/22 16:47:51
NME

Base Information

Drug NameLL-K8-22
Drug Alias NameLL-K-8-22LL-K8-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCDK8-Cyclin C Complex degraders
TargetsCDK8-Cyclin C Complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A